Probenecid, a gout remedy, inhibits pannexin 1 channels

William Silverman, Silviu Locovei, Gerhard Dahl

Research output: Contribution to journalArticle

237 Citations (Scopus)

Abstract

Probenecid is a well-established drug for the treatment of gout and is thought to act on an organic anion transporter, thereby affecting uric acid excretion in the kidney by blocking urate reuptake. Probenecid also has been shown to affect ATP release, leading to the suggestion that ATP release involves an organic anion transporter. Other pharmacological evidence and the observation of dye uptake, however, suggest that the nonvesicular release of ATP is mediated by large membrane channels, with pannexin 1 being a prominent candidate. In the present study we show that probenecid inhibited currents mediated by pannexin 1 channels in the same concentration range as observed for inhibition of transport processes. Probenecid did not affect channels formed by connexins. Thus probenecid allows for discrimination between channels formed by connexins and pannexins.

Original languageEnglish
JournalAmerican Journal of Physiology - Cell Physiology
Volume295
Issue number3
DOIs
StatePublished - Sep 1 2008

Fingerprint

Probenecid
Gout
Organic Anion Transporters
Connexins
Adenosine Triphosphate
Uric Acid
Ion Channels
Coloring Agents
Observation
Pharmacology
Kidney
Pharmaceutical Preparations

Keywords

  • ATP release
  • Connexin
  • Erythrocyte
  • Transport

ASJC Scopus subject areas

  • Cell Biology
  • Physiology

Cite this

Probenecid, a gout remedy, inhibits pannexin 1 channels. / Silverman, William; Locovei, Silviu; Dahl, Gerhard.

In: American Journal of Physiology - Cell Physiology, Vol. 295, No. 3, 01.09.2008.

Research output: Contribution to journalArticle

@article{332c137a0b24497790890619e14a4c02,
title = "Probenecid, a gout remedy, inhibits pannexin 1 channels",
abstract = "Probenecid is a well-established drug for the treatment of gout and is thought to act on an organic anion transporter, thereby affecting uric acid excretion in the kidney by blocking urate reuptake. Probenecid also has been shown to affect ATP release, leading to the suggestion that ATP release involves an organic anion transporter. Other pharmacological evidence and the observation of dye uptake, however, suggest that the nonvesicular release of ATP is mediated by large membrane channels, with pannexin 1 being a prominent candidate. In the present study we show that probenecid inhibited currents mediated by pannexin 1 channels in the same concentration range as observed for inhibition of transport processes. Probenecid did not affect channels formed by connexins. Thus probenecid allows for discrimination between channels formed by connexins and pannexins.",
keywords = "ATP release, Connexin, Erythrocyte, Transport",
author = "William Silverman and Silviu Locovei and Gerhard Dahl",
year = "2008",
month = "9",
day = "1",
doi = "10.1152/ajpcell.00227.2008",
language = "English",
volume = "295",
journal = "American Journal of Physiology - Cell Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Probenecid, a gout remedy, inhibits pannexin 1 channels

AU - Silverman, William

AU - Locovei, Silviu

AU - Dahl, Gerhard

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Probenecid is a well-established drug for the treatment of gout and is thought to act on an organic anion transporter, thereby affecting uric acid excretion in the kidney by blocking urate reuptake. Probenecid also has been shown to affect ATP release, leading to the suggestion that ATP release involves an organic anion transporter. Other pharmacological evidence and the observation of dye uptake, however, suggest that the nonvesicular release of ATP is mediated by large membrane channels, with pannexin 1 being a prominent candidate. In the present study we show that probenecid inhibited currents mediated by pannexin 1 channels in the same concentration range as observed for inhibition of transport processes. Probenecid did not affect channels formed by connexins. Thus probenecid allows for discrimination between channels formed by connexins and pannexins.

AB - Probenecid is a well-established drug for the treatment of gout and is thought to act on an organic anion transporter, thereby affecting uric acid excretion in the kidney by blocking urate reuptake. Probenecid also has been shown to affect ATP release, leading to the suggestion that ATP release involves an organic anion transporter. Other pharmacological evidence and the observation of dye uptake, however, suggest that the nonvesicular release of ATP is mediated by large membrane channels, with pannexin 1 being a prominent candidate. In the present study we show that probenecid inhibited currents mediated by pannexin 1 channels in the same concentration range as observed for inhibition of transport processes. Probenecid did not affect channels formed by connexins. Thus probenecid allows for discrimination between channels formed by connexins and pannexins.

KW - ATP release

KW - Connexin

KW - Erythrocyte

KW - Transport

UR - http://www.scopus.com/inward/record.url?scp=53449101616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53449101616&partnerID=8YFLogxK

U2 - 10.1152/ajpcell.00227.2008

DO - 10.1152/ajpcell.00227.2008

M3 - Article

C2 - 18596212

AN - SCOPUS:53449101616

VL - 295

JO - American Journal of Physiology - Cell Physiology

JF - American Journal of Physiology - Cell Physiology

SN - 0363-6143

IS - 3

ER -